<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02561260</url>
  </required_header>
  <id_info>
    <org_study_id>2014-1-1101-2</org_study_id>
    <nct_id>NCT02561260</nct_id>
  </id_info>
  <brief_title>Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Tongren Hospital</source>
  <brief_summary>
    <textblock>
      In recent years, more and more previously thought to be unknown encephalitis was found to be
      a specific antigen associated encephalitisï¼Œbut because of the lack of recognition in the
      clinic, usually been misdiagnosed as other causes of encephalitis. Therefore, it is urgent to
      establish a database of autoimmune encephalitis in Chinese population. The prospective
      clinical trial of atutoimmune encephalitis in China, by screening the autoimmune encephalitis
      associated antibody and summarizing the cases analysis, in order to provide evidence for
      clinical diagnosis and treatment of autoimmune encephalitis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>30days</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Autoimmune Encephlitis in China</condition>
  <arm_group>
    <arm_group_label>autoimmune encephalitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>unknowm encephalitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>other encephalopathy</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The unidentified encephalitis patients who meeting the inclusion criteria and exclusion
        criteria and signed a written informed consent.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Older than 6 months.

          2. Encephalopathy symptoms (change of mental state and consciousness level) persist for
             more than 24 hours;

          3. At least one or more clinical features of the followings: fever, epilepsy, focal
             neurological deficiency symptoms, changes in CSF(cerebrospinal fluid inflammatory),
             changes in EEG (electroencephalogram), radiographic abnormalities;

          4. Clinical suspected encephalitis, but conventional detected methods cannot make
             etiology clear.

          5. Signed the informed consent.

        Exclusion Criteria:

          1. Infants less than 6 months;

          2. The metabolic encephalopathy;

          3. Infectious encephalitis with clear pathogen clinically, referring the specific
             pathogenic microorganisms, including: bacteria, virus, fungus, parasite, spirochete
             and so on;

          4. Non-infectious encephalitis with clear diagnosis clinically, including: multiple
             sclerosis, neuromyelitis optic, acute disseminated encephalomyelitis and so on.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2015</study_first_submitted>
  <study_first_submitted_qc>September 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2015</study_first_posted>
  <last_update_submitted>September 27, 2015</last_update_submitted>
  <last_update_submitted_qc>September 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tongren Hospital</investigator_affiliation>
    <investigator_full_name>Jia Wei Wang,MD</investigator_full_name>
    <investigator_title>Chairman and Full Professor of Department of Neurology and Medical Research Center</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

